...
首页> 外文期刊>Journal of cellular and molecular medicine. >Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat model.
【24h】

Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat model.

机译:在同等大小的颅骨缺损大鼠模型中评估用同基因成骨细胞播种的已加工牛松质骨基质。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

INTRODUCTION: Biologic bone substitutes may offer alternatives to bone grafting procedures. The aim of this study was to evaluate a preformed bone substitute based on processed bovine cancellous bone (PBCB) with or without osteogenic cells in a critical size calvarial defect rat model. METHODS: Discs of PBCB (Tutobone) were seeded with second passage fibrin gel-immobilized syngenic osteoblasts (group A, n = 40). Cell-free matrices (group B, n = 28) and untreated defects (group C; n=28) served as controls. Specimens were explanted between day 0 and 4 months after implantation and were subjected to histological and morphometric evaluation. RESULTS: At 1 month, bone formation was limited to small peripheral areas. At 2 and 4 months, significant bone formation, matrix resorption as well as integration of the implants was evident in groups A and B. In group C no significant regeneration of the defects was observed. Morphometric analysis did not disclose differences in bone formation in matrices from groups A and B. Carboxyfluorescine-Diacetate-Succinimidylester (CFDA) labeling demonstrated low survival rates of transplanted cells. DISCUSSION: Osteoblasts seeded into PBCB matrix display a differentiated phenotype following a 14 days cell culture period. Lack of initial vascularization may explain the absence of added osteogenicity in constructs from group A in comparison to group B. PBCB is well integrated and represents even without osteogenic cells a promising biomaterial for reconstruction of critical size calvarial bone defects.
机译:简介:生物骨替代物可能提供替代骨移植程序的方法。这项研究的目的是在临界大小的颅骨缺损大鼠模型中评估基于加工过的牛松质骨(PBCB)的成骨替代品,该骨具有或不具有成骨细胞。方法:将第二代纤维蛋白凝胶固定的同基因成骨细胞(A组,n = 40)接种到PBCB(兔骨)椎间盘上。无细胞基质(B组,n = 28)和未处理的缺陷(C组; n = 28)作为对照。在植入后的第0至4个月之间将样本移出,并进行组织学和形态计量学评估。结果:在1个月时,骨形成仅限于较小的外围区域。在第2和第4个月,在A组和B组中,明显的骨形成,基质吸收以及植入物的整合明显。在C组中,未观察到明显的缺损再生。形态计量分析未揭示A组和B组矩阵中骨形成的差异。羧荧光二乙酸双琥珀酰亚胺酯(CFDA)标记显示移植细胞的存活率较低。讨论:接种到PBCB基质中的成骨细胞在经过14天的细胞培养期后表现出分化的表型。缺乏初始血管形成可能解释了与B组相比,A组的构建体没有增加的成骨性。PBCB很好地整合,即使没有成骨细胞,也代表了重建关键尺寸颅盖骨缺损的有前途的生物材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号